Research Communications Senior Writer

Current Employees and Students:
Please log in to Workday to use the internal job search and application process.

Dr. Li is widely recognized for his pioneering contributions at the interface of immune regulation, proteostasis, and translational immuno‑oncology. Over the past two decades, his laboratory has established key principles linking endoplasmic reticulum (ER) proteostasis to immune function. His team was among the first to apply mammalian genetics to elucidate the in vivo roles of GRP
94/gp96
, an ER‑resident HSP
90 paralog, demonstrating its function as a client‑restricted, ATP‑dependent immune chaperone essential for the organization of Toll‑like receptors, integrins, Wnt co‑receptors, the GARP–TGF‑β axis, and platelet biology. These discoveries helped launch the field of immune chaperone biology and have produced multiple translational innovations, including gp96‑based cancer vaccines and first‑in‑human anti‑GARP CAR‑T therapies
.

The Research Communications Senior Writer will collaborate closely with the Li Lab to translate scientific concepts, discoveries, and ongoing initiatives into clear, accurate, and compelling written materials. Responsibilities will include the development of manuscripts
, grant applications
, post‑award scientific reports
, industry‑sponsored research agreements
, patent‑related documents
, clinical trial protocols
, IND applications
, scientific presentations
, research process documentation
, and strategic communications such as marketing materials. Through these efforts, the Senior Writer will support the laboratory’s mission by effectively communicating the significance, innovation, and impact of PIIO’s research at the forefront of immuno‑oncology.

Bachelor's degree or equivalent experience. Advanced degree in relevant field may be desirable. 4 years of relevant experience required. 4-8 years of relevant experience preferred.

Function: Marketing and Communications

Sub Function: Research Communications

Career Band: Individual Contributor - Specialized

Career Level: S3

The OSUCCC – James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a freestanding cancer hospital on the campus of one of the nation’s largest public universities.

The Pelotonia Institute for Immuno-Oncology (PIIO) is a comprehensive bench-to-bedside research enterprise focused on advancing cancer immunotherapy through fundamental discovery, translational research, and clinical innovation.

Screen reader users may encounter difficulty with the online application. For assistance with applying, please contact hr-accessible application. If you have questions while submitting an application, please review these frequently asked questions.

Thank you for your interest in working at Ohio State.

Final candidates are subject to successful completion of a background check. A drug screen or physical may be required during the post offer process.

The university is an equal opportunity employer, including veterans and disability.